Clinical Trials Browser

Ear Diseases × Clear all

Congenital Abnormalities, Urogenital Diseases, Mental Disorders, Chromosome Aberrations, Communicable Diseases, Digestive System Diseases, Ear Diseases, Eye Diseases, Metabolic Diseases, Neoplasms, Nervous System Diseases, Poisoning, Respiration Disorders, Skin Diseases, Wounds and Injuries

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Phase 1/2 Unknown

80 enrolled

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

Clinical Trials

AnovaOS Network Powered Patient Registry

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.